Dr. Jérémie Mortier
Institut für Pharmazie
Postdoctoral researcher
Molecular dynamics studies of polypeptides, development of novel Arginase inhibitors
Address
Freie Universität Berlin
Institut für Pharmazie
Königin-Luisestr. 2+4
Room 277
14195 Berlin
Institut für Pharmazie
Königin-Luisestr. 2+4
Room 277
14195 Berlin
Telephone
Fax
+49 30 545 4 52686
| Titel/Autor | Jahr | ||
| Inhibitory potency of flavonoid derivatives on influenza virus neuraminidase C Rakers, SM Schwerdtfeger, J Mortier, S Duwe, T Wolff, G Wolber, ... Bioorganic & Medicinal Chemistry Letters |
2014 | ||
| Discovery of Sanggenon G as a natural cell-permeable small-molecular weight inhibitor of X-linked inhibitor of apoptosis protein (XIAP) MA Seiter, S Salcher, M Rupp, J Hagenbuchner, U Kiechl-Kohlendorfer, ... FEBS Open Bio |
2014 | ||
| Synthesis, Biological Evaluation, and Docking Studies of New 2‐Furylbenzimidazoles as Anti‐Angiogenic Agents: Part II A Temirak, YM Shaker, FAF Ragab, MM Ali, SM Soliman, J Mortier, ... Archiv der Pharmazie 347 (4), 291-304 |
2014 | ||
| Balancing selectivity vs stability using molecular dynamics and umbrella sampling J Mortier, EK Nyakatura, M Miettinen, C Baldauf, G Wolber, B Koksch Journal of cheminformatics 6 (Suppl 1), O22 |
2014 | ||
| An Unusual Interstrand H-Bond Stabilizes the Heteroassembly of Helical αβγ-Chimeras with Natural Peptides EK Nyakatura, R Rezaei Araghi, J Mortier, S Wieczorek, C Baldauf, ... ACS chemical biology 9 (3), 613-616 |
2014 | ||
| Synthesis, biological activity and structure–activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells R Ottanà, R Maccari, J Mortier, A Caselli, S Amuso, G Camici, A Rotondo, ... European journal of medicinal chemistry 71, 112-127 |
2014 | ||
| Design, synthesis and structure–activity relationship of novel quinoxaline derivatives as cancer chemopreventive agent by inhibition of tyrosine kinase receptor SA Galal, AS Abdelsamie, SM Soliman, J Mortier, G Wolber, MM Ali, ... European journal of medicinal chemistry 69, 115-124 |
2013 | ||
| Impact of fluorination on proteolytic stability of peptides in human blood plasma V Asante, J Mortier, H Schlüter, B Koksch Bioorganic & medicinal chemistry 21 (12), 3542-3546 |
2013 | ||
| Design, synthesis, inhibition studies, and molecular modeling of pepstatin analogues addressing different secreted aspartic proteinases of< i> Candida albicans</i> CD Cadicamo, J Mortier, G Wolber, M Hell, IE Heinrich, D Michel, ... Biochemical pharmacology 85 (7), 881-887 |
2013 | ||
| < i> In silico</i> virtual screening approaches for anti-viral drug discovery MS Murgueitio, M Bermudez, J Mortier, G Wolber Drug Discovery Today: Technologies 9 (3), e219-e225 |
3 | 2012 | |
| Computational tools for in silico fragment-based drug design J Mortier, C Rakers, R Frederick, G Wolber Current topics in medicinal chemistry 12 (17), 1935-1943 |
7 | 2012 | |
| A Simple Synthesis of D-Galactono-1, 4-Lactone and Key Building Blocks for the Preparation of Galactofuranosides VL de Talancé, E Thiery, G Eppe, SE Bkassiny, J Mortier, SP Vincent Journal of Carbohydrate Chemistry 30 (7-9), 605-617 |
2 | 2011 | |
| Anti-virulence strategy against Brucella suis: synthesis, biological evaluation and molecular modeling of selective histidinol dehydrogenase inhibitors MR Abdo, P Joseph, J Mortier, F Turtaut, JL Montero, B Masereel, ... Organic & biomolecular chemistry 9 (10), 3681-3690 |
4 | 2011 | |
| NF-κB inducing kinase (NIK) inhibitors: identification of new scaffolds using virtual screening J Mortier, B Masereel, C Remouchamps, C Ganeff, J Piette Bioorganic & medicinal chemistry letters 20 (15), 4515-4520 |
17 | 2010 | |
| Pyrazolo [4, 3-c] isoquinolines as potential inhibitors of NF-κB activation J Mortier, R Frederick, C Ganeff, C Remouchamps, P Talaga, L Pochet, ... Biochemical pharmacology 79 (10), 1462-1472 |
11 | 2010 | |